In fact, several previous case-control studies have documented elevated resistin levels in neurodegenerative disorders such as dementia [29], Alzheimer’s disease [30] and Multiple Sclerosis [31]. The gene discussed is RETN; the disease is early-onset autosomal dominant Alzheimer disease.